Nohla Therapeutics

Seattle

Nohla Therapeutics is a Seattle-based therapeutics company that Ben Bergo previously co-founded.

Facts

HQ
Seattle
Sectors
Biotech, Therapeutics
Stage
Series B
Members see funding amounts.
.

Is this your organization? Claim it

Seattle’s Deverra Therapeutics Raises $2.4M to Develop Cellular Immunotherapies with Fred Hutch License

Seattle biotech startup Deverra Therapeutics, founded by oncologist Colleen Delaney, is raising $2.4 million through debt and warrants to advance its cellular immunotherapy platform licensed from Fred Hutch. The company recently secured $3.5 million from the Andy Hill CARE Fund and licensed an immuno-oncology platform from Coeptis Therapeutics for $570,000 plus shares.

See all 9 stories, episodes and videos about Nohla Therapeutics.